H.R. 7346 · 117th Congress
John W. Walsh Alpha-1 Home Infusion Act of 2022
- Stage
- In committee
- Sponsor
- Maria Salazar
- Introduced
- 2022-03-31
- Latest action
- 2022-04-01 · Referred to the Subcommittee on Health.
Summary
John W. Walsh Alpha-1 Home Infusion Act of 2022
This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.